Literature DB >> 11701516

Antibody engineering.

J Maynard1, G Georgiou.   

Abstract

Antibodies are unique in their high affinity and specificity for a binding partner, a quality that has made them one of the most useful molecules for biotechnology and biomedical applications. The field of antibody engineering has changed rapidly in the past 10 years, fueled by novel technologies for the in vitro isolation of antibodies from combinatorial libraries and their functional expression in bacteria. This review presents an overview of the methods available for the de novo generation of human antibodies, for engineering antibodies with increased antigen affinity, and for the production of antibody fragments. Select applications of recombinant antibodies are also presented.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11701516     DOI: 10.1146/annurev.bioeng.2.1.339

Source DB:  PubMed          Journal:  Annu Rev Biomed Eng        ISSN: 1523-9829            Impact factor:   9.590


  59 in total

1.  Antibodies against Venom of the Snake Deinagkistrodon acutus.

Authors:  Chi-Hsin Lee; Yu-Ching Lee; Meng-Huei Liang; Sy-Jye Leu; Liang-Tzung Lin; Jen-Ron Chiang; Yi-Yuan Yang
Journal:  Appl Environ Microbiol       Date:  2015-10-16       Impact factor: 4.792

Review 2.  Continuing pursuit for ideal systemic anticancer radiotherapeutics.

Authors:  Marlein Miranda Cona; Huaijun Wang; Junjie Li; Yuanbo Feng; Feng Chen; Peter de Witte; Alfons Verbruggen; Yicheng Ni
Journal:  Invest New Drugs       Date:  2011-10-18       Impact factor: 3.850

3.  An engineered chaperonin caging a guest protein: Structural insights and potential as a protein expression tool.

Authors:  Masahiro Furutani; Jun-Ichi Hata; Yasuhito Shomura; Keisuke Itami; Takao Yoshida; Yoshitaka Izumoto; Akiko Togi; Akira Ideno; Takuo Yasunaga; Kunio Miki; Tadashi Maruyama
Journal:  Protein Sci       Date:  2005-02       Impact factor: 6.725

4.  T7 RNA polymerase-directed expression of an antibody fragment transgene in plastids causes a semi-lethal pale-green seedling phenotype.

Authors:  Alan M Magee; Seamus Coyne; David Murphy; Eva M Horvath; Peter Medgyesy; Tony A Kavanagh
Journal:  Transgenic Res       Date:  2004-08       Impact factor: 2.788

5.  Context-dependent mutations predominate in an engineered high-affinity single chain antibody fragment.

Authors:  Katarina S Midelfort; K Dane Wittrup
Journal:  Protein Sci       Date:  2006-02       Impact factor: 6.725

6.  Design, expression, and stability of a diverse protein library based on the human fibronectin type III domain.

Authors:  C Anders Olson; Richard W Roberts
Journal:  Protein Sci       Date:  2007-03       Impact factor: 6.725

7.  Self-assembly of antibodies by chemical induction.

Authors:  Qing Li; David Hapka; Hua Chen; Daniel A Vallera; Carston R Wagner
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

8.  Biotinylated single-chain variable fragment-based enzyme-linked immunosorbent assay for glycocholic acid.

Authors:  Xiping Cui; Natalia Vasylieva; Ding Shen; Bogdan Barnych; Jun Yang; Qiyi He; Zhengyun Jiang; Suqing Zhao; Bruce D Hammock
Journal:  Analyst       Date:  2018-04-30       Impact factor: 4.616

Review 9.  Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.

Authors:  Saul Tzipori; Abhineet Sheoran; Donna Akiyoshi; Arthur Donohue-Rolfe; Howard Trachtman
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

10.  Intracellular expression of a single domain antibody reduces cytotoxicity of 15-acetyldeoxynivalenol in yeast.

Authors:  Patrick J Doyle; Hanaa Saeed; Anne Hermans; Steve C Gleddie; Greg Hussack; Mehdi Arbabi-Ghahroudi; Charles Seguin; Marc E Savard; C Roger Mackenzie; J Christopher Hall
Journal:  J Biol Chem       Date:  2009-09-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.